Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.3M
-
Number of holders
-
99
-
Total 13F shares, excl. options
-
5.63M
-
Shares change
-
+1.07M
-
Total reported value, excl. options
-
$317M
-
Value change
-
+$99.2M
-
Number of buys
-
69
-
Number of sells
-
-33
-
Price
-
$56.39
Significant Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q4 2014
112 filings reported holding ANIP - ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share as of Q4 2014.
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) has 99 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.63M shares
of 22.3M outstanding shares and own 25.26% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (1.09M shares), State Street Corp (416K shares), WELLS FARGO & COMPANY/MN (332K shares), BlackRock Fund Advisors (323K shares), PERCEPTIVE ADVISORS LLC (313K shares), BlackRock Institutional Trust Company, N.A. (244K shares), VANGUARD GROUP INC (226K shares), Allianz Asset Management AG (226K shares), BOGLE INVESTMENT MANAGEMENT L P /DE/ (194K shares), and First Investors Management Co Inc (186K shares).
This table shows the top 99 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.